Transgene to Participate in the Biomed Forum Investor Conference Strasbourg (France), January 21, 2025, 5:45 PM CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops...
Transgene participera à la conférence investisseurs Biomed Forum Strasbourg (France), le 21 janvier 2025, 17 h 45 CET – Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et...
Strasbourg (France), January 21, 2025, 5:45 PM CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today...
Transgene présente son calendrier de communication financière pour 2025 Strasbourg (France), le 14 janvier 2025, 17 h 45 — Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit...
Transgene Announces Financial Calendar for 2025 Strasbourg (France), January 14, 2025, 5:45 p.m. CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based...
Strasbourg (France), January 14, 2025, 5:45 p.m. CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces...
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2024 Strasbourg, January 7, 2025 – 06:00 pm CET Under the liquidity contract entrusted by Transgene to Natixis...
Bilan du Contrat de Liquidité avec la Société Natixis Oddo BHF SCA au 31 décembre 2024 Strasbourg, le 7 janvier 2025 – 18h00 Au titre du contrat de liquidité confié par Transgene à Natixis Oddo...
Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024 Les données de...
TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck cancer setting Financial visibility confirmed into Q4 2025 Strasbourg...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.004 | -0.577200577201 | 0.693 | 0.699 | 0.681 | 24018 | 0.68333012 | DE |
4 | 0.009 | 1.32352941176 | 0.68 | 0.79 | 0.675 | 30397 | 0.7272906 | DE |
12 | -0.23 | -25.027203482 | 0.919 | 0.96 | 0.656 | 30410 | 0.7629042 | DE |
26 | -0.361 | -34.380952381 | 1.05 | 1.21 | 0.656 | 30585 | 0.92203524 | DE |
52 | -0.603 | -46.6718266254 | 1.292 | 1.52 | 0.656 | 31215 | 1.08422794 | DE |
156 | -1.571 | -69.5132743363 | 2.26 | 2.66 | 0.656 | 33211 | 1.72175801 | DE |
260 | -0.841 | -54.9673202614 | 1.53 | 3.15 | 0.656 | 71243 | 1.96910797 | DE |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관